Journal article
Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
- Abstract:
- The anti-influenza drug oseltamivir is an ester prodrug activated by hepatic carboxylesterases. Plasma esterases also convert up to 31.8% of the parent compound to the active metabolite after 4 h ex vivo, with wide interindividual variation. This source of error is removed by adding the esterase inhibitor dichlorvos to blood collection tubes.
- Publication status:
- Published
Actions
Authors
- Journal:
- Antimicrobial agents and chemotherapy More from this journal
- Volume:
- 50
- Issue:
- 9
- Pages:
- 3197-3199
- Publication date:
- 2006-09-01
- DOI:
- EISSN:
-
1098-6596
- ISSN:
-
0066-4804
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:27915
- UUID:
-
uuid:4ad0f9ea-adf1-4b88-b8b6-89143f5e682d
- Local pid:
-
pubs:27915
- Source identifiers:
-
27915
- Deposit date:
-
2012-12-19
Terms of use
- Copyright date:
- 2006
If you are the owner of this record, you can report an update to it here: Report update to this record